The Partnership for Clean Competition aims to promote a holistic understanding of anti-doping. To move toward that goal, we’ve put together a selection of articles published in February 2021 that are relevant to clean sport. These articles may or may not stem from PCC-funded research. Posting them here should not be read as an endorsement of findings, but rather, an attempt to assemble the latest research in one place to make it easy to read and review.
Boardley ID, Chandler M, Backhouse SH, Petróczi A. Co-creating a social science research agenda for clean sport: An international Delphi study. Int J Drug Policy. 2021 Feb [12:10]3161. doi: 10.1016/j.drugpo.2021.103161. Epub ahead of print. PMID: 33589380. https://pubmed.ncbi.nlm.nih.gov/33589380/
Keen B, Cawley A, Fouracre C, Pyke J, Fu S. Towards an untargeted mass spectrometric approach for improved screening in equine anti-doping. Drug Test Anal. 2021 Feb 25. doi: 10.1002/dta.3021. Epub ahead of print. PMID: 33629815. https://pubmed.ncbi.nlm.nih.gov/33629815/
Kintz P, Gheddar L, Raul JS. Simultaneous testing for anabolic steroids in human hair specimens collected from various anatomic locations has several advantages when compared with the standard head hair analysis. Drug Test Anal. 2021 Feb 25. doi: 10.1002/dta.3020. Epub ahead of print. PMID: 33634609. https://pubmed.ncbi.nlm.nih.gov/33634609/
Savill R, Baues H, Voigt E, Zierau O, Thieme D, Keiler AM. Cell culture as a toolbox to generate phase I metabolites for antidoping screening. Drug Test Anal. 2021 Feb 1. doi: 10.1002/dta.3009. Epub ahead of print. PMID: 33527655. https://pubmed.ncbi.nlm.nih.gov/33527655/
Smith T, Fedoruk M, Eichner A. Performance-Enhancing Drug Use in Recreational Athletes. Am Fam Physician. 2021 Feb 15;103(4):203-204. PMID: 33587578. https://pubmed.ncbi.nlm.nih.gov/33587578/
Thevis M, Kuuranne T, Thomas A, Geyer H. Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings. Drug Test Anal. 2021 Feb 4. doi: 10.1002/dta.3011. Epub ahead of print. PMID: 33538088. https://pubmed.ncbi.nlm.nih.gov/33538088/
If you have ideas, questions, or potentially relevant research to include, please contact Communications Director David Kumbroch at dkumbroch@cleancompetition.org.
